Patrick Emmet Duffy, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

None Reported

None Reported

Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection.
Science
Volume: 344
Date: 05 2014
www.ncbi.nlm.nih.gov/pubmed/24855263

Parasite burden and severity of malaria in Tanzanian children.
N Engl J Med
Volume: 370
Date: 05 2014
www.ncbi.nlm.nih.gov/pubmed/24806160

Preparing for future efficacy trials of severe malaria vaccines.
Vaccine
Volume: 34
Date: 01 2016

VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
Journal of Infectious Diseases
pii: JIW197
Date: 05 2016

Hemoglobin variants shape the distribution of malaria parasites in human populations and their transmission potential.
Scientific Reports
Volume: 7
Date: 10 2017
www.ncbi.nlm.nih.gov/pubmed/29079846

Systemic Inflammatory Response to Malaria During Pregnancy Is Associated With Pregnancy Loss and Preterm Delivery.
Clinical Infectious Diseases
Volume: 65
Date: 10 2017
www.ncbi.nlm.nih.gov/pubmed/29020221

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.
PLoS One
Volume: 12
Date: 12 2017
www.ncbi.nlm.nih.gov/pubmed/29281708

Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania.
PLoS Neglected Tropical Diseases
Volume: 12
Date: 03 2018
www.ncbi.nlm.nih.gov/pubmed/29579050

Development of a bivalent conjugate vaccine candidate against malaria transmission and typhoid fever.
Vaccine
Volume: 36
Date: 05 2018
www.ncbi.nlm.nih.gov/pubmed/29681410

Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults
Lancet Infectious Diseases
Volume: 18
Date: 09 2018
https://pubmed.ncbi.nlm.nih.gov/30061051/